News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
|
Followers
|
25
|
Posters
|
|
|
Posts (Today)
|
0
|
Posts (Total)
|
720
|
|
Created
|
01/01/18
|
Type
|
Free
|
| Moderators | |||
Phone: 1-519-601-4230
Toll Free: 1-855-325-0001
Fax: 1-866-796-0477
Email: london@medi-green.ca
Location: 211 Dundas Street
London, ON N6A 1G4
Canada NewsWire
TORONTO, Dec. 13, 2018
TORONTO, Dec. 13, 2018 /CNW/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce that, following a detailed application and inspection process, it has received its Good Manufacturing Practices ("GMP") certification.
TORONTO, Nov. 29, 2018
51% increase in revenues from Q1
with 250% increase forecasted for Q3
Strong Revenue Growth Expected for rest of Fiscal 2018
TORONTO, Nov. 29, 2018 /PRNewswire/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") announces today the release of its Interim Condensed Consolidated Financial Statements for the second quarter ended September 30, 2018, together with its Management, Discussion and Analysis ("MD&A"). These documents will be posted on the Company's website at www.beleave.com and SEDAR at www.sedar.com. All values in this news release and the Company's financial disclosures are in Canadian dollars unless otherwise stated.
SECOND QUARTER 2018 OPERATIONAL AND FINANCIAL HIGHLIGHTS
This was a landmark quarter for Beleave as sales from Cannabis began and new distribution channels for the upcoming quarters were established. The Company had revenues of $315,617 that didn't include recreational sales that began in October, however it was an improvement over last quarter's revenues of $208,617.
Significant reductions in costs were evident and, most notably, management and consulting fees were reduced substantially to $161,123 from the previous quarter. Salaries, professional services and change in fair value of note payable reductions were also very significant. On a comparative basis, the net loss in Q1 2018 was significantly reduced in Q2 2018 to $4,804,994, or $0.01 per share, as management focuses on cost reductions and revenue growth for the future.
"We're happy to report on our second quarter that included many highlights and developments for Beleave," said Andrew Wnek, Beleave's CEO. "We announced substantial facilities projects in London, Ontario and British Columbia, acquired Seven Oaks to bolster our recreational product lines, expanded our Medi-Green network of stores in Ontario and Quebec, and moved forward with plans for Colombian operations. We look forward to an even stronger third quarter that will reflect recreational sales and increased revenues."
Beleave also wishes to advise that it is named in a temporary order issued by the Executive Director of the British Columbia Securities Commission (BCSC) concerning certain purchases of and trading in the securities of Beleave and 10 other CSE issuers by a group of consultants referred to as the "BridgeMark Group". Beleave is examining the matters raised by the BCSC, and the underlying contracts, and the services provided by members of the BridgeMark Group. Beleave intends to cooperate fully with the BCSC's examination of these matters.
